Kazia Therapeutics Ltd and its flagship asset have made significant progress against brain cancers: Pitt Street Research
Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) has more good news to come out, including results from a Phase 3 trial against glioblastoma, data from several...